Companies Vigil Neuroscience
Vigil Neuroscience (VIGL): executive pay, fiscal 2024
Free brief. Every figure links to the company’s own filing.
Email me Vigil Neuroscience’s executive pay brief as a PDF
It arrives in about 2 minutes, with every figure cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $3,847,287FY2023
- $2,633,571FY2024
CEO total pay was $2,633,571 in fiscal 2024, down from $3,847,287 in fiscal 2023.
FY2024: salary $620,000 · bonus $0 · stock awards $0 · option awards $1,692,871
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Ivana Magovčević-Liebisch | $620,000 | $0 | $0 | $1,692,871 | $306,900 | $0 | $13,800 | $2,633,571 |
| President and Chief Executive Officer | ||||||||
| Petra Kaufmann | 380,000 | 0 | 0 | 704,550 | 139,860 | 0 | 43,437 | 1,267,847 |
| Chief Medical Officer | ||||||||
| Jennifer Ziolkowski | 463,000 | 0 | 0 | 595,907 | 174,088 | 0 | 13,800 | 1,246,795 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Ivana Magovčević-Liebisch | $2,633,571 | $3,847,287 | — | ↓ −1,213,716 |
| Petra Kaufmann | 1,267,847 | — | — | — |
| Jennifer Ziolkowski | 1,246,795 | 1,703,032 | — | ↓ −456,237 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The company targets a general competitive position based on independent third-party benchmark analytics to inform the mix of base salary, bonus, and long-term incentives. Compensation is designed to motivate employees to achieve short- and long-term results in the best interests of stockholders, align executive interests with stockholders through equity grants, and promote retention.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2024
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jennifer Ziolkowski | Option | 4,508 | 9.57 | — |
| Jennifer Ziolkowski | Option | 6,246 | 3.78 | — |
| Jennifer Ziolkowski | Option | 7,496 | 3.78 | — |
| Ivana Magovčević-Liebisch | Option | 9,015 | 9.57 | — |
| Jennifer Ziolkowski | Option | 16,009 | 6.02 | — |
| Ivana Magovčević-Liebisch | Option | 19,085 | 1.89 | — |
| Jennifer Ziolkowski | Option | 34,375 | 3.03 | — |
| Ivana Magovčević-Liebisch | Option | 67,583 | 6.02 | — |
| Jennifer Ziolkowski | Option | 75,938 | 3.03 | — |
| Ivana Magovčević-Liebisch | Option | 88,125 | 3.03 | — |
| Jennifer Ziolkowski | Option | 126,750 | 3.39 | — |
| Ivana Magovčević-Liebisch | Option | 208,125 | 3.03 | — |
| Ivana Magovčević-Liebisch | Option | 376,188 | 3.39 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Bruce Booth, D.PhilIndependent · Compensation | $0 | — | $143,731 | — | — | $143,731 |
| Samantha Budd Haeberlein, Ph.DIndependent · Audit · Nominating and Corporate Governance | 50,110 | — | 73,731 | — | — | 123,841 |
| Mary ThistleIndependent · Audit (Chair) | 55,000 | — | 64,944 | — | — | 119,944 |
| Suzanne Bruhn, Ph.DIndependent · Audit · Compensation | 0 | — | 116,790 | — | — | 116,790 |
| Cheryl Renee Blanchard, Ph.DIndependent · Compensation (Chair) · Nominating and Corporate Governance | 0 | — | 116,440 | — | — | 116,440 |
| Gerhard Koenig, Ph.DIndependent | 40,907 | — | 61,545 | — | — | 102,452 |
| Stefan Vitorovic, MS, MBAIndependent · Nominating and Corporate Governance (Chair) | 48,000 | — | 51,062 | — | — | 99,062 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 10,000 / 8,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $194,017 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $194,017 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Vigil Neuroscience as a peer
Companies that benchmark against VIGL
4 companies name VIGL as a compensation peer
- Amylyx Pharmaceuticals, Inc.AMLXFY2025
- Astria Therapeutics, Inc.ATXSFY2024
- DiaMedica Therapeutics Inc.DMACFY2025
- Voyager Therapeutics, Inc.VYGRFY2025
Each company listed discloses VIGL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named VIGL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2024
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Vigil Neuroscience | 2024 | Ivana Magovčević-Liebisch | $620,000 | $0 | $1,692,871 | $306,900 | $2,633,571 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (13 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Ivana Magovčević-Liebisch. DEF 14A, filed 2025-03-31. Section “Executive Compensation”. As printed: 2,633,571. View filing ↗
- Section 01, Petra Kaufmann. DEF 14A, filed 2025-03-31. Section “Executive Compensation”. As printed: 1,267,847. View filing ↗
- Section 01, Jennifer Ziolkowski. DEF 14A, filed 2025-03-31. Section “Executive Compensation”. As printed: 1,246,795. View filing ↗
- Section 08, Bruce Booth, D.Phil. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 143,731. View filing ↗
- Section 08, Samantha Budd Haeberlein, Ph.D. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 123,841. View filing ↗
- Section 08, Mary Thistle. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 119,944. View filing ↗
- Section 08, Suzanne Bruhn, Ph.D. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 116,790. View filing ↗
- Section 08, Cheryl Renee Blanchard, Ph.D. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 116,440. View filing ↗
- Section 08, Gerhard Koenig, Ph.D. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 102,452. View filing ↗
- Section 08, Stefan Vitorovic, MS, MBA. DEF 14A, filed 2025-03-31. Section “Director Compensation”. As printed: 99,062. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 194,017 + equity 0 + all other 0 = 194,017, summed across the director compensation table rows.
- Vigil Neuroscience (subject), Section 10b CEO total. DEF 14A, filed 2025-03-31. CEO total compensation as printed in Vigil Neuroscience's own proxy. As printed: 2,633,571. View filing ↗